Spark Therapeutics, Bluebird CEOs formulate a Super Bowl wager

Add one more bet to the lengthy list of "friendly" wagers politicians, business leaders and even brewery operators and art institutions in Philadelphia and Boston are making on the outcome of Super Bowl LII. Spark Therapeutics CEO Jeffrey Marrazzo bet Nick Leschly, CEO of Bluebird Bio in Cambridge, Mass., that the Philadelphia Eagles will beat the New England Patriots. Leschly accepted the wager. Here's what's at stake for leaders of the gene therapies companies. While the first part of the…
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Source Type: news